Pathophysiology of Shivering After FFP Transfusion and How to management
A table detailing the management of patients experiencing shivering after FFP transfusion based on whether they can eat (NPO status) or not:
| Condition | Management of Patient Can Eat | Management of Patient is NPO |
|---|---|---|
| Shivering | ||
| Immune Response | ||
| Allergic Reaction | - Cetirizine (10 mg orally once daily) | - Cetirizine (10 mg IV if available, otherwise avoid) |
| - Loratadine (10 mg orally once daily) | - Loratadine (10 mg IV if available, otherwise avoid) | |
| - Acetaminophen (500-1000 mg orally every 6 hours) | - Acetaminophen (500-1000 mg IV every 6 hours) | |
| - Hydration with oral fluids | - IV fluids to maintain hydration | |
| Non-Immune | ||
| Hypothermia | - Warm oral fluids | - Warm IV fluids |
| - Warm blankets | - Warm blankets | |
| Febrile Non-Hemolytic Transfusion Reaction (FNHTR) | ||
| - Acetaminophen (500-1000 mg orally every 6 hours) | - Acetaminophen (500-1000 mg IV every 6 hours) | |
| - Hydration with oral fluids | - IV fluids to maintain hydration | |
| - Monitor temperature | - Monitor temperature | |
| Severe Allergic Reactions/Inflammatory Responses | ||
| CPM | - Chlorpheniramine (4 mg orally every 6-8 hours) | - Chlorpheniramine (10-20 mg IV every 6-12 hours) |
| - Hydrocortisone (if needed, 20 mg orally) | - Hydrocortisone (100 mg IV bolus) | |
| - Methylprednisolone (if needed, 4 mg orally) | - Methylprednisolone (40-125 mg IV) | |
| General Measures | ||
| - Monitor vital signs | - Monitor vital signs | |
| - Educate patient about possible reactions | - Educate patient about possible reactions | |
| - Encourage rest | - Ensure patient comfort and rest |
Introduction Shivering after the transfusion of Fresh Frozen Plasma (FFP) is a clinical symptom that can cause discomfort and indicate an adverse reaction to the transfusion. Understanding the pathophysiology behind this reaction is crucial for effective management and treatment. This article explores the mechanisms leading to shivering post-FFP transfusion and outlines the appropriate medical interventions and dosages for treating this symptom.
Pathophysiology of Shivering Post-FFP Transfusion
- Immune Response to Transfused Plasma
- Allergic Reactions: Shivering can result from an allergic reaction to plasma proteins in the transfused FFP. This reaction is typically mild but can trigger the release of histamines and other inflammatory mediators.
- Cytokine Release: The introduction of donor plasma can activate immune cells, leading to the release of cytokines such as interleukins and tumor necrosis factor (TNF), which can induce shivering.
- Non-Immune Mechanisms
- Hypothermia: FFP is usually stored at very low temperatures and can cause a drop in body temperature when transfused rapidly. This hypothermic effect can directly induce shivering as the body attempts to generate heat.
- Metabolic Effects: Rapid infusion of cold FFP can affect the body's metabolic rate and thermoregulation processes, contributing to shivering.
- Acute Transfusion Reactions
- Febrile Non-Hemolytic Transfusion Reaction (FNHTR): This common type of reaction occurs due to the presence of donor leukocytes and cytokines in the FFP. It is characterized by fever and chills, including shivering.
- Transfusion-Related Acute Lung Injury (TRALI): Although rare, TRALI is a serious reaction that can present with symptoms including shivering, due to immune-mediated damage to the lungs.
Assessment and Management
When managing shivering after FFP transfusion, it's crucial to first assess the patient for any signs of anaphylaxis, which includes:
- Skin: Check for maculopapular rash (MP rash), urticaria, or angioedema.
- Respiratory: Listen for wheezing, stridor, or difficulty breathing.
- Cardiovascular: Monitor for hypotension or tachycardia.
- Gastrointestinal: Look for symptoms like nausea, vomiting, or abdominal pain.
Based on whether the patient can eat (is not NPO) or is NPO, the approach to management varies.
- If the Patient Can Eat
- Acetaminophen (Paracetamol)
- Indication: Used to reduce fever and alleviate discomfort associated with shivering.
- Dosage: 500-1000 mg orally every 6 hours as needed (maximum 4,000 mg in 24 hours).
- Cetirizine or Loratadine
- Indication: Used to counteract mild allergic reactions causing shivering.
- Dosage: Cetirizine 10 mg orally once daily or Loratadine 10 mg orally once daily.
- Hydration and Warmth
- Provide warm oral fluids and cover the patient with warm blankets to counteract hypothermia.
- Acetaminophen (Paracetamol)
- If the Patient is NPO
- Acetaminophen (Paracetamol)
- Indication: Used to reduce fever and alleviate discomfort associated with shivering.
- Dosage: 500-1000 mg IV every 6 hours as needed (maximum 4,000 mg in 24 hours).
- Chlorpheniramine (CPM)
- Indication: Used to counteract mild allergic reactions causing shivering.
- Dosage: 10-20 mg intravenously every 6-12 hours as needed.
- Hydrocortisone
- Indication: Used for severe allergic reactions or in cases of persistent shivering not responding to antihistamines.
- Dosage: 100 mg IV bolus in emergency situations.
- Methylprednisolone (Solu-Medrol)
- Indication: Used for severe inflammatory or allergic reactions.
- Dosage: 40-125 mg IV, based on the severity of symptoms.
- Hydration and Warmth
- Provide warm IV fluids and cover the patient with warm blankets to counteract hypothermia.
- Acetaminophen (Paracetamol)
Important Note: Always perform a thorough physical examination to rule out anaphylaxis, which includes checking for MP rash, wheezing, hypotension, and other signs of severe allergic reactions. Immediate intervention is required if any signs of anaphylaxis are detected.
Conclusion
Shivering after FFP transfusion is a multifactorial symptom that can arise from immune and non-immune mechanisms. Proper management involves identifying the underlying cause and administering appropriate medications to alleviate the symptoms. Understanding the pathophysiology of shivering and the pharmacological interventions available ensures effective treatment and improves patient comfort and safety during transfusions. Always consult with a healthcare provider for tailored medical advice and treatment plans.